PTAB Institutes IPR of Ansell’s Patent

February 3, 2017 – The Patent Trial and Appeal Board instituted Reckitt Benckiser’s petition for inter partes review of claims 1-20 of Ansell Healthcare Products LLC’s U.S. Patent No. 9,074,029, entitled “Dip-formed synthetic polyisoprene latex articles with improved intraparticle and interparticle crosslinks.”

The case is pending before the Patent Trial and Appeal Board, IPR2017-00066.

By: Joyce L. Nadipuram